Phathom Pharmaceuticals Scheduled to Report Q3 2026 Earnings
Phathom Pharmaceuticals (PHAT) is set to release its third-quarter 2026 financial results on Thursday, October 29th, prior to the market opening. Investors are closely watching for updates regarding revenue growth and earnings performance as the company continues its commercial trajectory. Market consensus estimates project a quarterly revenue of $84.82 million, representing a significant year-over-year increase of 71.4%. The estimated earnings per share (EPS) is -$0.14, which reflects a 6.7% improvement compared to the same period last year.
Tickers: $PHAT